Analysts expect CytoDyn Inc. to report revenue of 0.00 for Q3 20, against a range of 0.00 to 0.00.
| Metric | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | - | - | - | - | - | - | ||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect CytoDyn Inc. to report earnings per share of -0.05 for Q3 20, against a range of -0.05 to -0.05.
| Metric | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | - | - | - | - | - | - | ||
| High Estimate | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 | ||
| Low Estimate | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 | ||
| Consensus Estimate | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 |
Pull Wall Street consensus for CytoDyn Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CYDY&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CYDY", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CYDY&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();